Alan D. D'Andrea
Corporate Officer/Principal bei Harvard University
Profil
Alan D.
D'Andrea is the founder of Cedilla Therapeutics, Inc. (founded in 2017).
Dr. D'Andrea is also the founder of The DNA Repair Co...
Dr. D'Andrea's current job(s) include being a Professor at Harvard University and the Chief-Division of Genomic Stability & DNA Repair at Dana-Farber Cancer Institute, Inc. Dr. D'Andrea's education history includes obtaining a doctorate degree from Harvard University in 1983.
Aktive Positionen von Alan D. D'Andrea
| Unternehmen | Position | Beginn |
|---|---|---|
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Dana-Farber Cancer Institute, Inc.
 Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Alan D. D'Andrea
| Unternehmen | Position | Ende |
|---|---|---|
The DNA Repair Co.
 The DNA Repair Co. Medical/Nursing ServicesHealth Services The DNA Repair Co. develops cancer diagnostics solutions. The firm produces DNA Repair biomarkers which reveal therapeutic solutions for cancer drugs. The company was founded by Alan D’Andrea, William A. Haseltine, Michael B. Yaffe, and Markus Grompe and is headquartered in Boston, MA. | Gründer | 03.11.2009 |
Cedilla Therapeutics, Inc.
 Cedilla Therapeutics, Inc. BiotechnologyHealth Technology Cedilla Therapeutics, Inc. operats as a biotechnology company. It engages in discovering and exploiting insights into protein stability. The company was founded by Alan D. D?Andrea, Steve Gygi, Matthew P. Jacobson, William G. Kaelin, Jr. and Jack Taunton on September 6, 2017 and is headquartered in Cambridge, MA. | Gründer | - |
Ausbildung von Alan D. D'Andrea
| Harvard University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
The DNA Repair Co.
The DNA Repair Co. Medical/Nursing ServicesHealth Services The DNA Repair Co. develops cancer diagnostics solutions. The firm produces DNA Repair biomarkers which reveal therapeutic solutions for cancer drugs. The company was founded by Alan D’Andrea, William A. Haseltine, Michael B. Yaffe, and Markus Grompe and is headquartered in Boston, MA. | Health Services |
Dana-Farber Cancer Institute, Inc.
Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | Health Services |
Cedilla Therapeutics, Inc.
Cedilla Therapeutics, Inc. BiotechnologyHealth Technology Cedilla Therapeutics, Inc. operats as a biotechnology company. It engages in discovering and exploiting insights into protein stability. The company was founded by Alan D. D?Andrea, Steve Gygi, Matthew P. Jacobson, William G. Kaelin, Jr. and Jack Taunton on September 6, 2017 and is headquartered in Cambridge, MA. | Health Technology |
